openPR Logo
Press release

Intravenous Immunoglobulin Market to Capture Remarkable Growth USD 24.13 Billion with a Stunning 7.50% CAGR through 2032 | Key Players-Baxter International Inc, BDI Pharma Inc, Biotest AG

07-24-2024 07:35 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market

Intravenous immunoglobulin is a commodity constituted of human antibodies that can be provided intravenously. Antibodies are proteins the body renders to assist in battling specific infections. Each antibody rendered by the body is moderately dissimilar because it suits like a lock and key to each distant material that enters the body.

During the lifetime, the body fabricates thousands of varied antibodies as one is subjected to varied contagious entities that the body contemplates to be distant. Intravenous immunoglobulin can be extremely effective at prohibiting and curing contaminations in persons who do not possess antibodies or who possess low levels of antibodies.

๐Š๐ž๐ฒ ๐’๐ญ๐š๐ญ๐ฌ

โ€ข The global intravenous immunoglobulin market was valued at USD 12.66 billion in 2023.
โ€ข The industry is expected to grow at a CAGR of 7.50% during the forecast period.
โ€ข By 2032, the market is expected to reach USD 24.13 billion.

๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

Intravenous immunoglobulin operates by initiating antibodies from fit persons into the bloodstream of patients, offering passive resilience. These antibodies can offset pathogens, improve immune responses, and decrease the gravity of the duration of the infection.
Furthermore, the growing existence of immunodeficiency illnesses can be credited to several factors, such as enhanced diagnostic techniques, growing consciousness, and superior comprehension of these situations among healthcare experts.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

The market is splintered and is expected to observe contention due to many player's existence. These players concentrate on alliances, commodity improvements, and partnerships to acquire a canniness amongst their co-workers and seize a notable market share.

๐’๐จ๐ฆ๐ž ๐Ž๐Ÿ ๐“๐ก๐ž ๐‚๐ฎ๐ซ๐ซ๐ž๐ง๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐ˆ๐ง ๐“๐ก๐ž ๐ˆ๐ง๐ญ๐ซ๐š๐ฏ๐ž๐ง๐จ๐ฎ๐ฌ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ซ๐ž:
โ€ข Baxter International Inc.
โ€ข BDI Pharma Inc.
โ€ข Biotest AG
โ€ข China Biologics Products Inc.
โ€ข CSL Behring
โ€ข Grifols SA
โ€ข Kedrion Biopharma
โ€ข LFB Biotechnologies
โ€ข Octapharma AG

๐‚๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐๐ž๐ฅ๐จ๐ฐ ๐‹๐ข๐ง๐ค ๐ญ๐จ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/131/2

๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ:

โ€ข Patient-Centric Care: Focus on improving patient convenience and compliance through home-based IVIG infusions and user-friendly delivery systems.
โ€ข Personalized Medicine: Advances in personalized medicine approaches enhance the efficacy of IVIG therapy tailored to individual patient needs.
โ€ข Supply Chain Improvements: Efforts to streamline supply chains and ensure consistent availability of IVIG products to meet growing demand.
โ€ข Regulatory Approvals: Accelerated regulatory approvals for new IVIG products and indications facilitate market growth.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

โ€ข North American region held a dominant position in the Intravenous immunoglobulin market due to an excessively progressive healthcare framework that reinforces the growth of the IVIG market in the region. With a growing aggregate of cancer patients and the existence of critical players such as Baxter International Inc., productive drugs are growing in the market.

โ€ข Asia Pacific is anticipated to develop at the quickest rate in the market over the forecast period due to it having a sizeable population involving excessively populated nations such as India and China.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‚๐ฅ๐ข๐œ๐ค ๐‡๐ž๐ซ๐ž: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

๐๐ฒ ๐‚๐จ๐ฆ๐ฉ๐จ๐ง๐ž๐ง๐ญ
โ€ข IGG
โ€ข IGA
โ€ข IGM
โ€ข IGE
โ€ข IGD

๐๐ฒ ๐‘๐จ๐ฎ๐ญ๐ž ๐จ๐Ÿ ๐€๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง
โ€ข Intravenous
โ€ข Subcutaneous

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ€ข Hypogammaglobulinemia
โ€ข Chronic Inflammatory demyelinating polyneuropathy (CIDP)
โ€ข Immunodeficiency diseases
โ€ข Myasthenia Gravis
โ€ข Multifocal motor neuropathy
โ€ข Idiopathic thrombocytopenic purpura (ITP)

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ๐ฌ
โ€ข Hospitals
โ€ข Homecare
โ€ข Specialty Clinics

๐๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ž๐ฅ
โ€ข Hospital Pharmacy
โ€ข Retail Pharmacy
โ€ข Online Pharmacies

๐ˆ๐ง๐ญ๐ซ๐š๐ฏ๐ž๐ง๐จ๐ฎ๐ฌ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

โ€ข During the forecast period, the IgG segment is expected to be the largest. IgG has been extensively researched in clinical trials, which has resulted in its widespread use and acceptance in the medical field. These studies have demonstrated IgG's efficacy and safety in treating various autoimmune disorders, neurological conditions, and other immune-related diseases.

โ€ข The immunodeficiency diseases segment held the largest market share in 2022. Immunodeficiency diseases can be categorized into two types: primary (inherited) and secondary (acquired). Primary immunodeficiencies are typically genetic and present from birth, while secondary immunodeficiencies can develop later in life due to factors such as infections, medications, or medical treatments.

โ€ข Hospitals accounted for the highest share in 2022. Hospital pharmacies monitor patients receiving IVIG therapy, collaborate with healthcare professionals to track patient progress, and report any adverse events or reactions to regulatory bodies.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐–๐ข๐๐ž-๐ซ๐š๐ง๐ ๐ข๐ง๐  ๐‚๐จ๐ฏ๐ž๐ซ๐š๐ ๐ž ๐จ๐Ÿ ๐๐Œ๐‘'๐ฌ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

Hand Sanitizer Market: https://www.polarismarketresearch.com/industry-analysis/hand-sanitizer-market

Home Healthcare Market: https://www.polarismarketresearch.com/industry-analysis/home-healthcare-market

Active Pharmaceutical Ingredient Market: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Electrosurgical Devices Market: https://www.polarismarketresearch.com/industry-analysis/electrosurgical-devices-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Immunoglobulin Market to Capture Remarkable Growth USD 24.13 Billion with a Stunning 7.50% CAGR through 2032 | Key Players-Baxter International Inc, BDI Pharma Inc, Biotest AG here

News-ID: 3595620 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Building Information Modeling (BIM) Market to Hit USD 21.06 Billion by 2034 | Rising at a CAGR of 10.3%
Building Information Modeling (BIM) Market to Hit USD 21.06 Billion by 2034 | Ri โ€ฆ
The building information modeling market is projected to grow from USD 7.92 billion in 2024 to USD 21.06 billion by 2034; it is expected to expand at a CAGR of 10.3% from 2025 to 2034. Global government mandates, supportive policies, and rising investments in smart city development are driving increased demand for BIM. Building Information Modeling Explanation Building information modeling, or BIM, is a digital process that involves creating and managing detailed,โ€ฆ
Customer Relationship Management Market Set to Reach USD 198.10 Billion by 2034 with a CAGR of 11.5%
Customer Relationship Management Market Set to Reach USD 198.10 Billion by 2034 โ€ฆ
Customer Relationship Management Market The customer relationship management market size was valued at USD 66.85 billion in 2024. Looking forward, Polaris Market Research estimates the market to reach USD 198.10 billion by 2034, exhibiting a CAGR of 11.5% from 2025 to 2034. Customer relationship management, also called CRM, is a technology and strategy utilized by businesses to manage interactions with potential and current customers. It involves organizing, automating, and synchronizing sales, marketing,โ€ฆ
Metaverse Market Forecasts Impressive Growth, Set to Reach USD 4,798.77 Billion by 2034 with a CAGR of 46.3%
Metaverse Market Forecasts Impressive Growth, Set to Reach USD 4,798.77 Billion โ€ฆ
Metaverse Market Polaris Market Research has released a market assessment report titled, Metaverse Market - Forecast, 2025-2034. Market Overview The metaverse market was valued at USD 107.01 billion in 2024 and is expected to grow significantly, reaching USD 4,798.77 billion by 2034, registering a robust CAGR of 46.3% from 2025 to 2034. The metaverse is a collective virtual space created by the convergence of physical and digital realities, where users can interact with each otherโ€ฆ
Crime Risk Report Market Projected to Reach USD 64.00 Billion by 2034, Growing at a CAGR of 21.2%
Crime Risk Report Market Projected to Reach USD 64.00 Billion by 2034, Growing a โ€ฆ
Crime Risk Report Market The crime risk report market size was valued at USD 9.38 billion in 2024, according to Polaris Market Research's latest analysis. With a compound annual growth rate (CAGR) of 21.2% during 2025-2034, the market is projected to grow to USD 64.00 billion by 2034. What Is A Crime Risk Report? The crime risk report market revolves around the creation and distribution of detailed reports that assess the likelihood ofโ€ฆ

All 5 Releases


More Releases for Intravenous

Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USDโ€ฆ
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market isโ€ฆ
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illnessโ€ฆ
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term โ€œimmunoglobulinโ€ refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit fromโ€ฆ
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the โ€œPeripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021โ€œThe main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used toโ€ฆ
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence toโ€ฆ